Case Study: Novartis achieves faster time-to-value and major TCO savings with Dell Boomi AtomSphere iPaaS

Adoption of Dell Boomi AtomSphere iPaaS by Novartis

Novartis, a global pharmaceutical company, needed to replace two costly, inflexible on‑premise middleware platforms that had high per‑interface TCO, long upgrade cycles and heavy reliance on external system integrators. The business wanted faster time‑to‑value, greater agility for cloud and mobile scenarios, and a lower total cost of ownership.

After a proof‑of‑concept, Novartis selected Dell Boomi AtomSphere iPaaS. The POC completed a Salesforce integration in 25 hours and showed ~73% cost savings versus on‑premise. In production, the first migration phase delivered ~30% cost savings, a 50% reduction in server capacity, shortened development to 2–3 weeks, and enabled deployment of twice as many interfaces in a sixth of the time; Novartis plans broader cloud and mobile use and expects up to ~50% long‑term TCO reduction.

Novartis

Saurabh Sharma

Senior Analyst